Social pharma faces: Gary Monk (part 2)
Paul Tunnah interviews Gary Monk
(Continued from “Social pharma faces: Gary Monk (part 1)”)
Pharma is slowly learning to embrace the digital world as a new means to communicate with healthcare providers, payers and even patients. As pharmaphorum sees more and more such initiatives being undertaken, we thought it appropriate to embrace the spirit of social media and reach out to some of the key figures to discuss their experiences. We hope to be speaking with a number of such people, the “social pharma faces” to hear what they have to say.
Here, we continue with the second half of our discussion with Gary Monk, recent winner of the PM Society’s Digital Pioneer Award for his work at Janssen. Building on his observations last week on the challenges facing pharma in the online space, here Gary looks to the future around social media regulations, key game changers and critical success factors. In addition, we ask him to share his thoughts on what the future holds for digital pharma engagement and what the benefits could be for all stakeholder groups.
Click on the play button below to watch part 2.
Please add your comments below (you must be registered).
Subscribe to pharmaphorum on YouTube to hear about new videos – http://www.youtube.com/pharmaphorum.
About the interviewee:
Gary Monk is a serial innovator with a wealth of experience integrating new channels into pharma brand strategy. After a successful period at Janssen he recently won the PM society digital pioneer award and in 2011 moved to the consultancy firm Across Health. He can be contacted at Gary.email@example.com, through Twitter, Linkedin or by phone on +44 (0)7776 242276.
Across Health specialises in the integration of digital and innovative approaches with existing channels. This process starts with insights and strategy, with hands on expertise to support effective implementation and measurement of success. For more information visit www.a-cross.com/.
What will digital pharma engagement look like in 2015?